about
Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein responseDynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformationAutophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast CancerIs carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?Wnt pathway activation increases hypoxia tolerance during developmentCurrent relevance of hypoxia in head and neck cancerTauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13Molecular mechanisms of hypoxia in cancer.Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.Regulation of TRIB3 mRNA and protein in breast cancer.Multimodality imaging of hypoxia in preclinical settings.Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitorRegulation of hypoxia inducible factor-1α expression by the alteration of redox status in HepG2 cells.Hypoxia-inducible factor in thyroid carcinomaSystematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumorsRegional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumorsTribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response.Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathwayModulation of the tumor vasculature and oxygenation to improve therapyHypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant NeoplasiaA phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patientsAngiogenesis in upper tract urothelial carcinoma associated with Balkan endemic nephropathy.Function and expression of prolyl hydroxylase 3 in cancers.The tumor microenvironment: the making of a paradigm.Origin of Cancer: An Information, Energy, and Matter Disease.Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubes[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma.Radiobiology: state of the present art. A conference report.PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.A paradoxical chemoresistance and tumor suppressive role of antioxidant in solid cancer cells: a strange case of Dr. Jekyll and Mr. Hyde.Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma.Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.Use of infrared microspectroscopy to elucidate a specific chemical signature associated with hypoxia levels found in glioblastoma.The glutamine-alpha-ketoglutarate (AKG) metabolism and its nutritional implications.Hypometabolism as the ultimate defence in stress response: how the comparative approach helps understanding of medically relevant questions.Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinoma.HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions.
P2860
Q22000747-D110C000-9246-49D2-896D-F22431553562Q24624985-6E182F61-844E-4968-9802-37C0DC16BF70Q26753162-911BFBBB-A46D-484B-84EA-52C7A7ACFD3BQ26849504-2AE51A28-B904-4E48-86A9-40C0E19B4AE3Q27317418-1E6A346F-ABDB-43BE-BCF3-AF64D43F7F8BQ28074577-45C894C4-EBD1-44D9-83BD-B9D79158FC04Q28828990-4BA70323-B2BC-4080-8850-A4553E2695E7Q33705108-CA09F02E-2EA6-4B44-9B37-F71745D9D08CQ33898862-213744D8-BF0E-4C31-8690-8079A9709558Q34369602-04140E7D-5231-4D1F-8DEF-D55BD9625D49Q34436771-A846AF72-745C-49B5-86C0-287AD4EB7DC7Q34490037-5564F34C-1BFC-44AE-AD5F-EADE63C88A04Q34605956-FAD977D4-40A5-4742-86A6-18C7D59B1397Q34781159-5C52C97F-14A8-4A96-AAC3-0F8CADC5E4C1Q35041539-A4D0C4B2-63C0-42AC-872E-BA78AD89394CQ35099457-3BF96554-8F80-454D-B79E-E3001CA19B82Q35103263-A32CAE17-E54B-446C-9709-DF7A1752E948Q35221363-E587F420-688A-41C5-BBF6-6A78910FCFCAQ35608727-A6E86D1A-3F5A-4FEC-8515-2B0C15B589C0Q35632587-28AA879C-BB46-4508-9818-FFFC22CD395CQ35920685-D2747B3F-7B50-4358-9004-3D6E459F2713Q35932515-F4AFE62D-9111-472C-A427-4A45599D09E8Q36106434-FF7D7AA7-2E90-4705-B171-9FFDACED4FF7Q36224953-9038C667-B459-47D7-9548-2AA2563A241BQ37180139-8D89129F-1754-4002-8992-DD0C3FB063B6Q37373366-E292E6B7-B95C-416A-947D-A5750A1C2EEAQ37418612-BE8DC662-B278-4685-8F73-A139CA3958B1Q37594215-DBFEB349-3496-4795-8F8E-7A26657C5B27Q37636649-A48E678E-4EB8-4D8D-9CDD-45FD9ECED1D8Q37673206-5A0C0CC2-E666-46EF-886F-FFC86140485AQ37832131-B6989970-1D68-4705-B4D6-BA401308114CQ38209675-E2A0AAA6-B91D-4825-812E-850BADEFF0F8Q38263008-AEEB35E7-77B9-4D26-9D6E-AE3234B24F1EQ38344592-3F0756C4-2E4E-40B4-961B-09CFFFB13213Q38626024-D90AEA19-6D72-461B-B9DF-7589B6DC8FA4Q38810154-5AE35993-1C09-49F8-A286-2522047D238CQ38830220-54519E67-14CD-4386-A1CD-28B376316C36Q38882599-73648DE5-A18A-4198-96E3-C6A45BFAF22BQ39014917-441C6E83-0538-4666-A4B9-D0302A3AEF72Q39113716-D418730F-3716-42D4-BA06-4C083376ED4C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular aspects of tumour hypoxia.
@en
Molecular aspects of tumour hypoxia.
@nl
type
label
Molecular aspects of tumour hypoxia.
@en
Molecular aspects of tumour hypoxia.
@nl
prefLabel
Molecular aspects of tumour hypoxia.
@en
Molecular aspects of tumour hypoxia.
@nl
P2093
P2860
P1433
P1476
Molecular aspects of tumour hypoxia.
@en
P2093
Albert J van der Kogel
Fred C G J Sweep
Johannes H A M Kaanders
Paul N Span
Saskia E Rademakers
P2860
P356
10.1016/J.MOLONC.2008.03.006
P577
2008-03-27T00:00:00Z